At Café Scientifique, you can explore the latest ideas in science and technology in a relaxed setting. Enjoy listening to a short talk before engaging in debate and discussion with our guest speaker and audience
We’ll be joined by Dr Yutaka Matsubayashi on Tuesday 7 November from 6:30 – 8:00pm.
Many of us know that white blood cells help fight bacteria, but we may not be aware that they also act as tiny ‘couriers’, moving all around the body to deliver its building blocks. Without these couriers, the body cannot be constructed properly.
Join biologist Dr Yutaka Matsubayashi, from Bournemouth University, who will share video of these microscopic cells at work and discuss how important they are for the body’s structure. He will also explore whether they may have played a part in our evolutionary journey from single-celled organisms – and explain why thinking about stirring sugar into coffee can help us understand their function.
This event will be held at The Black Cherry in Boscombe, Bournemouth. Although the talks start at 6:30pm, the café will be open early so we encourage you to arrive early for a drink and a bite to eat before the talk starts.
If you have any questions about this event, or you’re interested in getting involved with a future Café Sci event, please email the Public Engagement with Research Team: publicengagement@bournemouth.ac.uk

Café Scientifique – Tuesday 6 June 2023: Repairing bodies with tissue engineering










BU academic publishes in online newspaper in Nepal
Final day of the ESRC Festival of Social Science
Using Art to enhance Research
Register now to attend the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease